Outsourcing pharma #vifor #pharma

Posted On Nov 8 2017 by

#outsourcing pharma # Outsourcing-Pharma.com The only free online news source covering the full spectrum of contract services to the pharmaceutical and biotechnology industries, from contract research and development through to manufacturing and commercial services. Outsourcing-Pharma.com covers issues such as: off-shoring strategies the rise of contact services – in Asia and other emerging markets product safety ethical clinical trials animal testing adaptive trial design and eclinical Key Contacts Related Brands Who we are Careers with us Resources Business terms and conditions


Novartis pharma head leaves as drug maker splits operations #helvoet #pharma

Posted On Nov 8 2017 by

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …


Pharmaceutical Purified Water Newsletter» – N° 4 to 7 – METTLER TOLEDO #pharma #agency

Posted On Nov 8 2017 by

#pharma newsletter # «Pharmaceutical Purified Water Newsletter» – N° 4 to 7 Perspectives in Pure Water Analytics Below to this section you can find all available «Pharmaceutical Purified Water News» in English for download in pdf-format. The newest release will always be placed on the bottom of the page. For more information on our pure water analytics solutions within the pharmaceutical USP industry, you can contact us by using the feedback button on the bottom of this page. We will be happy to assist you! «Pharmaceutical Purified Water News» N° 4 (12/04) – Headlines: Simplicity, the key to C lean-I …


Novartis splits drugs business into two, pharma chief to leave #plus #pharma

Posted On Nov 8 2017 by

#novartis pharma # Novartis splits drugs business into two, pharma chief to leave By John Miller and Ben Hirschler | ZURICH/LONDON ZURICH/LONDON (Reuters) – Novartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on other drugs, while switching out its current pharma head in the second high-profile management reshuffle this year. David Epstein, the American head of Novartis Pharmaceuticals and a 27-year veteran with the group, will leave the company to “explore new challenges from the U.S.”, Novartis said. Epstein’s re-location to the United States implies he is not in the running …


The Challenges Facing Emerging Markets Generic Pharmaceutical Companies #mayne #pharma

Posted On Nov 8 2017 by

#generic pharmaceutical companies # Additional Information: The Challenges Facing Emerging Markets Generic Pharmaceutical Companies By Thomas Ansen-Wilson The US generic drug market has been quite lucrative for EM pharma companies over the last decade. Many EM pharma companies have significantly outperformed the market by leveraging solid technological capabilities and low manufacturing costs. However, the future looks more difficult as a number of changes in the US market have made the landscape increasingly challenging. In the past, when there were fewer players in the market, the first few firms to launch a generic drug were able to generate profits for a …


Exchange-traded funds that hold big pharma – Market Realist #antares #pharma

Posted On Nov 8 2017 by

#big pharma etf # Exchange-traded funds that hold big pharma The VanEck Vectors Pharmaceutical ETF (PPH ) This fund has been operational since 2011 and has net assets of $345.54 million. Big pharma companies like Johnson Johnson (JNJ ), Novartis AG (NVS ), and Pfizer together form 24.61% of this fund’s total assets. The Health Care Select Sector SPDR Fund (XLV ) This fund has been operational since 1998 and has net assets of $13 billion. This ETF is focused on big pharma companies, healthcare equipment and supplies, and biotechnology companies. Big pharma companies including Johnson Johnson and Pfizer (PFE …


Pharma Pulse” Newsletter (Thai) – Issue 7 #shionogi #pharma

Posted On Nov 8 2017 by

#pharma newsletter # “Pharma Pulse” Newsletter (Thai) Issue 7 | Oct-Nov 2014 In this latest issue, you will find beneficial contents as in the following topics New Product. 5 new consumer health products newly launched Promotion Trends. Consumer health promotion in the top retailer “Boots” in the first half-year 2014 review, a good promotion guideline for pharmacy to see what’re hot products and promotions Store Management Tips. How to manage your staff, a good framework for pharmacies’ owners to manage their business Traditional Herbs Corner :“Ginger” ordinary herbs, not only an ingredient but also a great herbs that easy to …


The top 10 most expensive drugs of 2013 #natco #pharma

Posted On Nov 8 2017 by

#pharmaceutical companies news # The top 10 most expensive drugs of 2013 The price of Gilead Sciences’ breakthrough drug Sovaldi has drawn all of the attention this year. By pricing it at $85,000 for a 12-week course, Gilead Sciences ($GILD) has been pilloried by politicians, payers and providers. But as EvaluatePharma points out, at that price Sovaldi barely makes it into the top 20 most expensive drugs. number 19 to be exact, just above Novartis’ ($NVS) Gleevec and just below GlaxoSmithKline’s ($GSK) Mekinist. Sovaldi is pricey, but if you want to talk about really pricey, then look at the 10 …


Pharma Training and Education – NSF International #mds #pharma #services

Posted On Nov 8 2017 by

#pharma training # Training and Education Pharma Biotech Training NSF International is known all over the world for the high quality of its training and education. Whether you are looking to develop one of your people for career progression (including becoming a Qualified Person), to train a group of staff in house in changes in procedures and regulations, or to bring about culture change within an entire organization, we have the skills and programs to meet your needs. We offer courses in all areas of pharmaceutical GMP, including clinical trials, as well as training ranging from Qualified Person to pharmaceutical …


Pharma training #biochem #pharma

Posted On Nov 8 2017 by

#pharma training # Info-tréning Bt. Gyógyszeripari szakképzések Written by Administrator | 22 May 2016 There are no translations available. Örömmel adjuk hírül, hogy 2017. januárjában új CRA csoportok indulnak (VII. évfolyam), változatlan karrierlehetőségekkel és fakultatív kórházi gyakorlattal. A képzés ára nettó 384.000Ft. 2016 október 31-ig történő befizetés esetén pedig nettó 372.000Ft. A tematika a korábbival megegyező (bal oldali menüben is leírt 6 oktatási modul) lesz, kiegészítve az ICH GCP részletes ismertetésével. A részvételi szándékot az adatok megadásával itt lehet elkötelezettség nélkül jelezni. Várunk mindenkit szeretettel! Written by Administrator | 15 April 2012 There are no translations available. Feladatunknak tekintjük, hogy …